Withaferin A has been suggested to exert its anti-cancer properties through direct inhibition of HSP90/Cdc37 chaperone activity, induction of heat shock response and apoptosis following oxidative response in many cancer models [14, 18, 34]. This evidence concerns the gene CDC37 and cancer.